https://www.selleckchem.com/pr....oducts/gsk2193874.ht
The clinical success rate was 93%. Of the groups, the best French bleeding score decrease was obtained in the 900-1,200 μm group. There were improvements in the quality of life score and visual analogue scale score after the SRAE procedure, although not in the Goligher score. No recurrent disease was observed. SRAE with tris-acryl gelatin microspheres for symptomatic HD is a safe and efficient treatment, with results favoring the use of larger microspheres. SRAE with tris-acryl gelatin microspheres for symptomatic HD is a safe and ef
Like
Comment
Share
